Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: A serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm
-
Add time:08/04/2019 Source:sciencedirect.com
BackgroundErgosta-4,6,8(14),22-tetraen-3-one (cas 19254-69-4) (ergone) has been proven to prevent the progression of renal injury and the subsequent renal fibrosis. We investigated the therapeutic effects and mechanism of ergone on a chronic renal failure model of rats induced by adenine.
We also recommend Trading Suppliers and Manufacturers of Ergosta-4,6,8(14),22-tetraen-3-one (cas 19254-69-4). Pls Click Website Link as below: cas 19254-69-4 suppliers
Prev:Rapid resolution liquid chromatography–mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one
Next:Method development for simultaneous analyses of polycyclic aromatic hydrocarbons and their nitro-, oxy-, hydroxy- derivatives in sediments) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid resolution liquid chromatography–mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one08/03/2019
- Urinary metabonomics study on the protective effects of ergosta-4,6,8(14),22-tetraen-3-one on chronic renal failure in rats using UPLC Q-TOF/MS and a novel MSE data collection technique08/02/2019
- UPLC-Q-TOF/HSMS/MSE-based metabonomics for adenine-induced changes in metabolic profiles of rat faeces and intervention effects of ergosta-4,6,8(14),22-tetraen-3-one08/01/2019
- Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells07/31/2019
- Folate-functionalized nanoparticles for controlled ergosta-4,6,8(14),22-tetraen-3-one delivery07/30/2019